Annual Non Current Assets
$380.00 K
$0.000.00%
December 31, 2023
Summary
- As of February 6, 2025, XTLB annual long term assets is $380.00 thousand, unchanged on December 31, 2023.
- During the last 3 years, XTLB annual non current assets has fallen by -$2000.00 (-0.52%).
- XTLB annual non current assets is now -94.79% below its all-time high of $7.29 million, reached on December 31, 2012.
Performance
XTLB Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$7.29 M
+$6.91 M+1819.21%
September 30, 2024
Summary
- As of February 6, 2025, XTLB quarterly long term assets is $7.29 million, with the most recent change of +$6.91 million (+1819.21%) on September 30, 2024.
- Over the past year, XTLB quarterly non current assets has increased by +$6.91 million (+1819.21%).
- XTLB quarterly non current assets is now -0.01% below its all-time high of $7.29 million, reached on December 31, 2012.
Performance
XTLB Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
XTLB Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | +1819.2% |
| 3 y3 years | -0.5% | +1819.2% |
| 5 y5 years | 0.0% | +1809.2% |
XTLB Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.3% | at low | at high | +1819.2% |
| 5 y | 5-year | -0.5% | at low | at high | +1819.2% |
| alltime | all time | -94.8% | +68.1% | -0.0% | +5781.4% |
XTL Biopharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.29 M(+1819.2%) |
| Jun 2024 | - | $380.00 K(0.0%) |
| Mar 2024 | - | $380.00 K(0.0%) |
| Dec 2023 | $2.05 M(-46.2%) | $380.00 K(0.0%) |
| Sep 2023 | - | $380.00 K(0.0%) |
| Jun 2023 | - | $380.00 K(0.0%) |
| Mar 2023 | - | $380.00 K(0.0%) |
| Dec 2022 | $3.81 M(-39.0%) | $380.00 K(0.0%) |
| Sep 2022 | - | $380.00 K(-0.3%) |
| Jun 2022 | - | $381.00 K(0.0%) |
| Mar 2022 | - | $381.00 K(0.0%) |
| Dec 2021 | $6.24 M(+1.9%) | $381.00 K(-0.3%) |
| Sep 2021 | - | $382.00 K(0.0%) |
| Jun 2021 | - | $382.00 K(0.0%) |
| Mar 2021 | - | $382.00 K(0.0%) |
| Dec 2020 | $6.12 M(-10.4%) | $382.00 K(0.0%) |
| Sep 2020 | - | $382.00 K(+0.3%) |
| Jun 2020 | - | $381.00 K(-0.3%) |
| Mar 2020 | - | $382.00 K(0.0%) |
| Dec 2019 | $6.83 M(-16.7%) | $382.00 K(0.0%) |
| Sep 2019 | - | $382.00 K(0.0%) |
| Jun 2019 | - | $382.00 K(0.0%) |
| Mar 2019 | - | $382.00 K(+0.5%) |
| Dec 2018 | $8.20 M(+32.0%) | $380.00 K(0.0%) |
| Sep 2018 | - | $380.00 K(0.0%) |
| Jun 2018 | - | $380.00 K(0.0%) |
| Mar 2018 | - | $380.00 K(0.0%) |
| Dec 2017 | $6.21 M(+125.3%) | $380.00 K(-0.3%) |
| Sep 2017 | - | $381.00 K(+0.3%) |
| Jun 2017 | - | $380.00 K(-2.6%) |
| Mar 2017 | - | $390.00 K(+48.3%) |
| Dec 2016 | $2.75 M(-35.4%) | $263.00 K(-76.6%) |
| Sep 2016 | - | $1.12 M(+0.2%) |
| Jun 2016 | - | $1.12 M(-0.2%) |
| Mar 2016 | - | $1.12 M(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $4.26 M(+37.5%) | $1.06 M(-60.3%) |
| Sep 2015 | - | $2.67 M(+2.4%) |
| Jun 2015 | - | $2.60 M(+2.4%) |
| Dec 2014 | $3.10 M(-39.1%) | $2.54 M(-8.8%) |
| Sep 2014 | - | $2.79 M(-0.4%) |
| Jun 2014 | - | $2.80 M(-5.2%) |
| Mar 2014 | - | $2.95 M(+0.9%) |
| Dec 2013 | $5.09 M(+34.2%) | $2.93 M(-38.2%) |
| Sep 2013 | - | $4.73 M(-30.1%) |
| Jun 2013 | - | $6.78 M(-4.5%) |
| Mar 2013 | - | $7.09 M(-2.8%) |
| Dec 2012 | $3.79 M(+153.6%) | $7.29 M(+64.8%) |
| Sep 2012 | - | $4.42 M(+18.9%) |
| Jun 2012 | - | $3.72 M(-1.3%) |
| Mar 2012 | - | $3.77 M(+50.6%) |
| Dec 2011 | $1.50 M(+40.2%) | - |
| Sep 2011 | - | $2.50 M(-1.0%) |
| Jun 2011 | - | $2.53 M(-0.9%) |
| Mar 2011 | - | $2.55 M(-1.8%) |
| Dec 2010 | $1.07 M(+158.7%) | - |
| Sep 2010 | - | $2.60 M(+1226.0%) |
| Jun 2010 | - | $196.00 K(+11.4%) |
| Mar 2010 | - | $176.00 K(+41.9%) |
| Dec 2009 | $412.00 K(-85.9%) | - |
| Sep 2009 | - | $124.00 K(-48.3%) |
| Dec 2008 | $2.92 M(-79.0%) | - |
| Jun 2008 | - | $240.00 K(+6.2%) |
| Dec 2007 | $13.90 M(-46.7%) | $226.00 K(-6.2%) |
| Jun 2007 | - | $241.00 K(-70.0%) |
| Dec 2006 | $26.10 M(+89.2%) | $804.00 K(-18.5%) |
| Jun 2006 | - | $987.00 K(-27.4%) |
| Dec 2005 | $13.79 M(-42.0%) | $1.36 M(-0.3%) |
| Jun 2005 | - | $1.36 M(-26.3%) |
| Dec 2004 | $23.77 M(+3.5%) | $1.85 M(+5.4%) |
| Jun 2004 | - | $1.76 M |
| Dec 2003 | $22.97 M | - |
FAQ
- What is XTL Biopharmaceuticals annual long term assets?
- What is the all time high annual non current assets for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual non current assets year-on-year change?
- What is XTL Biopharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly non current assets year-on-year change?
What is XTL Biopharmaceuticals annual long term assets?
The current annual non current assets of XTLB is $380.00 K
What is the all time high annual non current assets for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual long term assets is $7.29 M
What is XTL Biopharmaceuticals annual non current assets year-on-year change?
Over the past year, XTLB annual long term assets has changed by $0.00 (0.00%)
What is XTL Biopharmaceuticals quarterly long term assets?
The current quarterly non current assets of XTLB is $7.29 M
What is the all time high quarterly non current assets for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly long term assets is $7.29 M
What is XTL Biopharmaceuticals quarterly non current assets year-on-year change?
Over the past year, XTLB quarterly long term assets has changed by +$6.91 M (+1819.21%)